跳至主要内容
临床试验/CTRI/2017/11/010706
CTRI/2017/11/010706已完成未知

â??Open label, prospective, multicentric trial to study the efficacy and safety ofStraw containing Sennoside with probiotic straw of Inzpera Healthâ??s sciences Limited in children with age group 5 to 12 years suffering from functional constipation.â??

Inzpera Healthsciences Ltd0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Children between the age group 5-12 years of age. (Both inclusive)
  • 2. Children suffering from functional constipation diagnosed with Rome III criteria.
  • 3. Parents or legal guardians willing to sign written informed consent form for the child.
  • 4. Children and parents / Guardians who agree to comply with study requirement and schedule.

排除标准

  • 1)Children having constipation secondary to any of other disorder like hypothyroidism, hirschprungâ??s disease and structural anomalies of anal canal.
  • 2)Children suffering from any type of infection having fever.
  • 3)Children not fulfilling Rome III criteria for functional constipation.
  • 4)Inability to keep return appointments.
  • 5)Children having sensitivity reaction to components of study medication (Sennoside with probiotic).
  • 6)Children with Type I diabetes.

研究者

发起方
Inzpera Healthsciences Ltd

相似试验